Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Yoga | 11 | 2024 | 88 | 5.120 |
Why?
|
| Caregivers | 19 | 2024 | 759 | 4.730 |
Why?
|
| Spouses | 16 | 2025 | 145 | 3.900 |
Why?
|
| Quality of Life | 29 | 2024 | 4810 | 3.090 |
Why?
|
| Mindfulness | 4 | 2022 | 56 | 2.760 |
Why?
|
| Stress, Psychological | 12 | 2025 | 1038 | 2.710 |
Why?
|
| Adaptation, Psychological | 18 | 2024 | 783 | 2.450 |
Why?
|
| Meditation | 8 | 2021 | 77 | 1.820 |
Why?
|
| Depression | 11 | 2024 | 1733 | 1.640 |
Why?
|
| Parenting | 4 | 2025 | 352 | 1.570 |
Why?
|
| Lung Neoplasms | 12 | 2023 | 12045 | 1.340 |
Why?
|
| Glioma | 3 | 2024 | 1986 | 1.070 |
Why?
|
| Writing | 5 | 2023 | 104 | 1.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2023 | 5582 | 1.020 |
Why?
|
| Social Support | 8 | 2023 | 585 | 0.940 |
Why?
|
| Proxy | 1 | 2024 | 24 | 0.940 |
Why?
|
| Videoconferencing | 2 | 2021 | 52 | 0.900 |
Why?
|
| Survivorship | 2 | 2024 | 116 | 0.830 |
Why?
|
| Bereavement | 1 | 2022 | 31 | 0.790 |
Why?
|
| Carcinoma, Renal Cell | 6 | 2020 | 2394 | 0.760 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2021 | 8 | 0.740 |
Why?
|
| Health Behavior | 3 | 2024 | 599 | 0.740 |
Why?
|
| Pilot Projects | 7 | 2024 | 2855 | 0.740 |
Why?
|
| Surveys and Questionnaires | 14 | 2024 | 5924 | 0.670 |
Why?
|
| Cancer Survivors | 2 | 2024 | 747 | 0.660 |
Why?
|
| Feasibility Studies | 7 | 2024 | 2360 | 0.650 |
Why?
|
| Head and Neck Neoplasms | 5 | 2024 | 4148 | 0.650 |
Why?
|
| Communication | 4 | 2025 | 841 | 0.640 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 82 | 0.610 |
Why?
|
| Neoplasms | 10 | 2024 | 15951 | 0.600 |
Why?
|
| Mind-Body Therapies | 1 | 2017 | 29 | 0.590 |
Why?
|
| Kidney Neoplasms | 4 | 2020 | 3116 | 0.590 |
Why?
|
| Middle Aged | 36 | 2025 | 90569 | 0.580 |
Why?
|
| Breast Neoplasms | 8 | 2025 | 16246 | 0.570 |
Why?
|
| Sleep Wake Disorders | 7 | 2017 | 371 | 0.560 |
Why?
|
| Survivors | 3 | 2018 | 1021 | 0.550 |
Why?
|
| Patient Care Planning | 1 | 2018 | 301 | 0.550 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2022 | 551 | 0.550 |
Why?
|
| Cross-Cultural Comparison | 1 | 2017 | 92 | 0.550 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 206 | 0.540 |
Why?
|
| Adult | 29 | 2025 | 82073 | 0.540 |
Why?
|
| Expressed Emotion | 1 | 2016 | 19 | 0.540 |
Why?
|
| Female | 39 | 2025 | 148936 | 0.520 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 1388 | 0.500 |
Why?
|
| Aged | 25 | 2024 | 73640 | 0.500 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 319 | 0.500 |
Why?
|
| Sexual Dysfunctions, Psychological | 2 | 2012 | 69 | 0.490 |
Why?
|
| Humans | 54 | 2025 | 270804 | 0.480 |
Why?
|
| Chemoradiotherapy | 1 | 2024 | 2038 | 0.480 |
Why?
|
| Male | 34 | 2025 | 128520 | 0.480 |
Why?
|
| Spirituality | 5 | 2020 | 130 | 0.480 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 4971 | 0.470 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2012 | 136 | 0.470 |
Why?
|
| Sexual Partners | 5 | 2020 | 105 | 0.460 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 277 | 0.450 |
Why?
|
| Parents | 3 | 2025 | 1083 | 0.410 |
Why?
|
| Emotions | 3 | 2023 | 558 | 0.410 |
Why?
|
| Family Relations | 1 | 2012 | 87 | 0.400 |
Why?
|
| Human papillomavirus 16 | 1 | 2013 | 255 | 0.390 |
Why?
|
| Fatigue | 6 | 2017 | 1292 | 0.360 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 4495 | 0.360 |
Why?
|
| Sexual Behavior | 1 | 2012 | 314 | 0.340 |
Why?
|
| Cost of Illness | 1 | 2013 | 506 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 2395 | 0.310 |
Why?
|
| Cognition | 1 | 2014 | 969 | 0.300 |
Why?
|
| Complementary Therapies | 2 | 2020 | 120 | 0.300 |
Why?
|
| Chronic Pain | 1 | 2011 | 265 | 0.290 |
Why?
|
| Cognition Disorders | 1 | 2013 | 762 | 0.290 |
Why?
|
| Interferon-alpha | 1 | 2011 | 957 | 0.280 |
Why?
|
| Life Style | 2 | 2021 | 617 | 0.280 |
Why?
|
| Treatment Outcome | 12 | 2024 | 33859 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 1225 | 0.250 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 3241 | 0.250 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 999 | 0.240 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2013 | 1162 | 0.240 |
Why?
|
| Qualitative Research | 3 | 2022 | 638 | 0.210 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 2051 | 0.210 |
Why?
|
| Self Report | 2 | 2024 | 794 | 0.200 |
Why?
|
| Grief | 1 | 2022 | 32 | 0.200 |
Why?
|
| Regression Analysis | 2 | 2017 | 1564 | 0.200 |
Why?
|
| Social Stigma | 1 | 2022 | 74 | 0.200 |
Why?
|
| Needs Assessment | 1 | 2023 | 235 | 0.190 |
Why?
|
| Ecological Momentary Assessment | 1 | 2021 | 21 | 0.190 |
Why?
|
| Perception | 2 | 2021 | 348 | 0.190 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 14639 | 0.180 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 31117 | 0.160 |
Why?
|
| Empathy | 1 | 2020 | 103 | 0.160 |
Why?
|
| Parish Nursing | 1 | 2018 | 2 | 0.160 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 42 | 0.160 |
Why?
|
| Social Adjustment | 1 | 2019 | 113 | 0.160 |
Why?
|
| Cyclonic Storms | 1 | 2019 | 68 | 0.150 |
Why?
|
| Terminal Care | 1 | 2023 | 467 | 0.150 |
Why?
|
| Oncologists | 1 | 2020 | 136 | 0.150 |
Why?
|
| Massage | 1 | 2017 | 14 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 5606 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3706 | 0.140 |
Why?
|
| Research Design | 1 | 2024 | 1562 | 0.140 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 244 | 0.140 |
Why?
|
| Young Adult | 4 | 2019 | 22255 | 0.130 |
Why?
|
| Family Characteristics | 2 | 2016 | 95 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 601 | 0.130 |
Why?
|
| Cluster Analysis | 1 | 2017 | 1076 | 0.120 |
Why?
|
| Qigong | 1 | 2014 | 12 | 0.120 |
Why?
|
| Tai Ji | 1 | 2014 | 16 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 899 | 0.120 |
Why?
|
| Waiting Lists | 2 | 2013 | 268 | 0.120 |
Why?
|
| Health Promotion | 1 | 2018 | 508 | 0.110 |
Why?
|
| Telemedicine | 1 | 2021 | 557 | 0.110 |
Why?
|
| Child | 3 | 2024 | 30572 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 4396 | 0.110 |
Why?
|
| Southwestern United States | 1 | 2013 | 60 | 0.110 |
Why?
|
| Affect | 1 | 2015 | 306 | 0.110 |
Why?
|
| Self Care | 1 | 2015 | 249 | 0.110 |
Why?
|
| Disease Management | 1 | 2019 | 1092 | 0.110 |
Why?
|
| Breathing Exercises | 1 | 2013 | 23 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2017 | 1061 | 0.110 |
Why?
|
| Self Efficacy | 1 | 2015 | 297 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 10 | 0.100 |
Why?
|
| Affective Symptoms | 1 | 2013 | 86 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1608 | 0.090 |
Why?
|
| Physicians | 1 | 2020 | 854 | 0.090 |
Why?
|
| Mental Health | 1 | 2013 | 408 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2023 | 17083 | 0.080 |
Why?
|
| Erectile Dysfunction | 1 | 2012 | 240 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 1145 | 0.080 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2011 | 694 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1250 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 637 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 15280 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5332 | 0.070 |
Why?
|
| Psychometrics | 1 | 2012 | 975 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 2180 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 2985 | 0.070 |
Why?
|
| United States | 3 | 2020 | 15834 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 3533 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12535 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 4320 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 5870 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 5053 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 2659 | 0.050 |
Why?
|
| Hydrocortisone | 2 | 2016 | 401 | 0.050 |
Why?
|
| Age Factors | 1 | 2012 | 5443 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2018 | 879 | 0.050 |
Why?
|
| Fear | 1 | 2023 | 259 | 0.050 |
Why?
|
| Prognosis | 1 | 2018 | 22533 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 17867 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2020 | 15 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2020 | 46 | 0.040 |
Why?
|
| Religion | 1 | 2020 | 95 | 0.040 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2017 | 20 | 0.040 |
Why?
|
| Muscle Stretching Exercises | 1 | 2017 | 14 | 0.040 |
Why?
|
| Causality | 1 | 2017 | 174 | 0.040 |
Why?
|
| Epirubicin | 1 | 2017 | 159 | 0.040 |
Why?
|
| Actigraphy | 1 | 2017 | 55 | 0.040 |
Why?
|
| Marriage | 1 | 2016 | 50 | 0.030 |
Why?
|
| Dental Care | 1 | 2015 | 12 | 0.030 |
Why?
|
| Disclosure | 1 | 2016 | 180 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 16751 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 144 | 0.030 |
Why?
|
| Sleep | 1 | 2017 | 444 | 0.030 |
Why?
|
| Language | 1 | 2016 | 331 | 0.030 |
Why?
|
| Taxoids | 1 | 2017 | 1019 | 0.030 |
Why?
|
| Exercise | 1 | 2021 | 1221 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 13422 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 1989 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 14037 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2020 | 2227 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 1469 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 1570 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 6881 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2017 | 3147 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2018 | 1464 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 3246 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 1027 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 4007 | 0.020 |
Why?
|
| Pain Management | 1 | 2015 | 716 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 677 | 0.020 |
Why?
|
| Comorbidity | 1 | 2015 | 2393 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 3395 | 0.020 |
Why?
|
| Mass Screening | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 5157 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9464 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 39982 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 5247 | 0.010 |
Why?
|